ScRNA-seq was applied to study promotion of the immunosuppressive microenvironment through changes such as the increased expression of protein disulfide isomerase family A member 3 (PDIA3) associated with PTEN loss and EGFR amplification in gliomas [131]. This evidence concerns the gene EGFR and central nervous system cancer.